Moreover, IL-37 levels are increased in the serum of patients with heart failure, atherosclerosis, and acute coronary syndromewith no evidence of anti-inflammatory effects.
The purpose of this study was to assess IL-37 profile in acute coronary syndrome (ACS) and the prognostic role of this cytokine in patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).